Predictors of Loss to Follow-Up Among Pediatric and Adult Hematopoietic Cell Transplantation Survivors: A Report from the Center for International Blood and Marrow Transplant Research.
Follow-up is integral for hematopoietic cell transplantation (HCT) care to ensure surveillance and intervention for complications. We characterized the incidence of and predictors for being lost to follow-up. Two-year survivors of first allogeneic HCT (10,367 adults and 3865 children) or autologous HCT (7291 adults and 467 children) for malignant/nonmalignant disorders between 2002 and 2013 reported to the Center for International Blood and Marrow Transplant Research were selected. The cumulative incidence of being lost to follow-up (defined as having missed 2 consecutive follow-up reporting periods) was calculated. Marginal Cox models (adjusted for center effect) were fit to evaluate predictors. The 10-year cumulative incidence of being lost to follow-up was 13% (95% confidence interval [CI], 12% to 14%) in adult allogeneic HCT survivors, 15% (95% CI, 14% to 16%) in adult autologous HCT survivors, 25% (95% CI, 24% to 27%) in pediatric allogeneic HCT survivors, and 24% (95% CI, 20% to 29%) in pediatric autologous HCT survivors. Factors associated with being lost to follow-up include younger age, nonmalignant disease, public/no insurance (reference: private), residence farther from the tranplantation center, and being unmarried in adult allogeneic HCT survivors; older age and testicular/germ cell tumor (reference: non-Hodgkin lymphoma) in adult autologous HCT survivors; older age, public/no insurance (reference: private), and nonmalignant disease in pediatric allogeneic HCT survivors; and older age in pediatric autologous HCT survivors. Follow-up focusing on minimizing attrition in high-risk groups is needed to ensure surveillance for late effects.
['Buchbinder|David|D|', 'Brazauskas|Ruta|R|', 'Bo-Subait|Khalid|K|', 'Ballen|Karen|K|', 'Parsons|Susan|S|', 'John|Tami|T|', 'Hahn|Theresa|T|', 'Sharma|Akshay|A|', 'Steinberg|Amir|A|', "D'Souza|Anita|A|", 'Kumar|Anita J|AJ|', 'Yoshimi|Ayami|A|', 'Wirk|Baldeep|B|', 'Shaw|Bronwen|B|', 'Freytes|César|C|', 'LeMaistre|Charles|C|', 'Bredeson|Christopher|C|', 'Dandoy|Christopher|C|', 'Almaguer|David|D|', 'Marks|David I|DI|', 'Szwajcer|David|D|', 'Hale|Gregory|G|', 'Schouten|Harry|H|', 'Hashem|Hasan|H|', 'Schoemans|Hélène|H|', 'Murthy|Hemant S|HS|', 'Lazarus|Hillard M|HM|', 'Cerny|Jan|J|', 'Tay|Jason|J|', 'Yared|Jean A|JA|', 'Adekola|Kehinde|K|', 'Schultz|Kirk R|KR|', 'Lehmann|Leslie|L|', 'Burns|Linda|L|', 'Aljurf|Mahmoud|M|', 'Diaz|Miguel Angel|MA|', 'Majhail|Navneet|N|', 'Farhadfar|Nosha|N|', 'Kamble|Rammurti|R|', 'Olsson|Richard|R|', 'Schears|Raquel|R|', 'Seo|Sachiko|S|', 'Beattie|Sara|S|', 'Chhabra|Saurabh|S|', 'Savani|Bipin N|BN|', 'Badawy|Sherif|S|', 'Ganguly|Siddhartha|S|', 'Ciurea|Stefan|S|', 'Marino|Susana|S|', 'Gergis|Usama|U|', 'Kuwatsuka|Yachiyo|Y|', 'Inamoto|Yoshihiro|Y|', 'Khera|Nandita|N|', 'Hashmi|Shahrukh|S|', 'Wood|William|W|', 'Saber|Wael|W|']
D000328:Adult D000368:Aged D002648:Child D005500:Follow-Up Studies D018380:Hematopoietic Stem Cell Transplantation D006801:Humans D017741:Survivors D019172:Transplantation Conditioning D014184:Transplantation, Homologous
Survivor Lost to follow-up Bone marrow transplantation Stem cell transplantation